Agriculture
Global Cyazofamid Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 27, 25
- ID: 162456
- Pages: 65
- Figures: 68
- Views: 6
The global Cyazofamid market size was US$ 116 million in 2024 and is forecast to a readjusted size of US$ 132 million by 2031 with a CAGR of 1.8% during the forecast period 2025-2031.
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.
Cyazofamid has good toxicological, environmental and ecotoxicological profiles.
In this report, we count technical grade and chapter 6 displays the preparation content.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, with the share of 81%.
The consumption shares of Japan, China, North America and Europe were 42%, 21%, 17% and 11%. Japan is the main import region and other countries need to import from Japan.
The global Cyazofamid market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
ISHIHARA SANGYO KAISHA
Rudong Zhongyi
By Type: (Dominant Segment vs High-Margin Innovation)
Agriculture Grade
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Downy Mildew
Oomycetes Diseases
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., ISHIHARA SANGYO KAISHA in Europe)
- Emerging Product Trends: Agriculture Grade adoption vs. Others premiumization
- Demand-Side Dynamics: Downy Mildew growth in China vs. Oomycetes Diseases potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Cyazofamid market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Others in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Oomycetes Diseases in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cyazofamid value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.
Cyazofamid has good toxicological, environmental and ecotoxicological profiles.
In this report, we count technical grade and chapter 6 displays the preparation content.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, with the share of 81%.
The consumption shares of Japan, China, North America and Europe were 42%, 21%, 17% and 11%. Japan is the main import region and other countries need to import from Japan.
The global Cyazofamid market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
ISHIHARA SANGYO KAISHA
Rudong Zhongyi
By Type: (Dominant Segment vs High-Margin Innovation)
Agriculture Grade
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Downy Mildew
Oomycetes Diseases
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., ISHIHARA SANGYO KAISHA in Europe)
- Emerging Product Trends: Agriculture Grade adoption vs. Others premiumization
- Demand-Side Dynamics: Downy Mildew growth in China vs. Oomycetes Diseases potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Cyazofamid market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Others in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Oomycetes Diseases in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cyazofamid value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Market Overview
1.1 Cyazofamid Product Scope
1.2 Cyazofamid by Type
1.2.1 Global Cyazofamid Sales by Type (2020 & 2024 & 2031)
1.2.2 Agriculture Grade
1.2.3 Others
1.3 Cyazofamid by Application
1.3.1 Global Cyazofamid Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Downy Mildew
1.3.3 Oomycetes Diseases
1.3.4 Others
1.4 Global Cyazofamid Market Estimates and Forecasts (2020-2031)
1.4.1 Global Cyazofamid Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Cyazofamid Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Cyazofamid Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Cyazofamid Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Cyazofamid Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Cyazofamid Sales Market Share by Region (2020-2025)
2.2.2 Global Cyazofamid Revenue Market Share by Region (2020-2025)
2.3 Global Cyazofamid Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Cyazofamid Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Cyazofamid Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Cyazofamid Market Size and Prospective (2020-2031)
2.4.2 Europe Cyazofamid Market Size and Prospective (2020-2031)
2.4.3 China Cyazofamid Market Size and Prospective (2020-2031)
2.4.4 Japan Cyazofamid Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Cyazofamid Historic Market Review by Type (2020-2025)
3.1.1 Global Cyazofamid Sales by Type (2020-2025)
3.1.2 Global Cyazofamid Revenue by Type (2020-2025)
3.1.3 Global Cyazofamid Price by Type (2020-2025)
3.2 Global Cyazofamid Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Cyazofamid Sales Forecast by Type (2026-2031)
3.2.2 Global Cyazofamid Revenue Forecast by Type (2026-2031)
3.2.3 Global Cyazofamid Price Forecast by Type (2026-2031)
3.3 Different Types Cyazofamid Representative Players
4 Global Market Size by Application
4.1 Global Cyazofamid Historic Market Review by Application (2020-2025)
4.1.1 Global Cyazofamid Sales by Application (2020-2025)
4.1.2 Global Cyazofamid Revenue by Application (2020-2025)
4.1.3 Global Cyazofamid Price by Application (2020-2025)
4.2 Global Cyazofamid Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Cyazofamid Sales Forecast by Application (2026-2031)
4.2.2 Global Cyazofamid Revenue Forecast by Application (2026-2031)
4.2.3 Global Cyazofamid Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Cyazofamid Application
5 Competition Landscape by Players
5.1 Global Cyazofamid Sales by Players (2020-2025)
5.2 Global Top Cyazofamid Players by Revenue (2020-2025)
5.3 Global Cyazofamid Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyazofamid as of 2024)
5.4 Global Cyazofamid Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Cyazofamid, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Cyazofamid, Product Type & Application
5.7 Global Key Manufacturers of Cyazofamid, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Cyazofamid Sales by Company
6.1.1.1 North America Cyazofamid Sales by Company (2020-2025)
6.1.1.2 North America Cyazofamid Revenue by Company (2020-2025)
6.1.2 North America Cyazofamid Sales Breakdown by Type (2020-2025)
6.1.3 North America Cyazofamid Sales Breakdown by Application (2020-2025)
6.1.4 North America Cyazofamid Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Cyazofamid Sales by Company
6.2.1.1 Europe Cyazofamid Sales by Company (2020-2025)
6.2.1.2 Europe Cyazofamid Revenue by Company (2020-2025)
6.2.2 Europe Cyazofamid Sales Breakdown by Type (2020-2025)
6.2.3 Europe Cyazofamid Sales Breakdown by Application (2020-2025)
6.2.4 Europe Cyazofamid Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Cyazofamid Sales by Company
6.3.1.1 China Cyazofamid Sales by Company (2020-2025)
6.3.1.2 China Cyazofamid Revenue by Company (2020-2025)
6.3.2 China Cyazofamid Sales Breakdown by Type (2020-2025)
6.3.3 China Cyazofamid Sales Breakdown by Application (2020-2025)
6.3.4 China Cyazofamid Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Cyazofamid Sales by Company
6.4.1.1 Japan Cyazofamid Sales by Company (2020-2025)
6.4.1.2 Japan Cyazofamid Revenue by Company (2020-2025)
6.4.2 Japan Cyazofamid Sales Breakdown by Type (2020-2025)
6.4.3 Japan Cyazofamid Sales Breakdown by Application (2020-2025)
6.4.4 Japan Cyazofamid Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 ISHIHARA SANGYO KAISHA
7.1.1 ISHIHARA SANGYO KAISHA Company Information
7.1.2 ISHIHARA SANGYO KAISHA Business Overview
7.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Revenue and Gross Margin (2020-2025)
7.1.4 ISHIHARA SANGYO KAISHA Cyazofamid Products Offered
7.1.5 ISHIHARA SANGYO KAISHA Recent Development
7.2 Rudong Zhongyi
7.2.1 Rudong Zhongyi Company Information
7.2.2 Rudong Zhongyi Business Overview
7.2.3 Rudong Zhongyi Cyazofamid Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Rudong Zhongyi Cyazofamid Products Offered
7.2.5 Rudong Zhongyi Recent Development
8 Cyazofamid Manufacturing Cost Analysis
8.1 Cyazofamid Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Cyazofamid
8.4 Cyazofamid Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Cyazofamid Distributors List
9.3 Cyazofamid Customers
10 Cyazofamid Market Dynamics
10.1 Cyazofamid Industry Trends
10.2 Cyazofamid Market Drivers
10.3 Cyazofamid Market Challenges
10.4 Cyazofamid Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Cyazofamid Product Scope
1.2 Cyazofamid by Type
1.2.1 Global Cyazofamid Sales by Type (2020 & 2024 & 2031)
1.2.2 Agriculture Grade
1.2.3 Others
1.3 Cyazofamid by Application
1.3.1 Global Cyazofamid Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Downy Mildew
1.3.3 Oomycetes Diseases
1.3.4 Others
1.4 Global Cyazofamid Market Estimates and Forecasts (2020-2031)
1.4.1 Global Cyazofamid Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Cyazofamid Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Cyazofamid Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Cyazofamid Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Cyazofamid Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Cyazofamid Sales Market Share by Region (2020-2025)
2.2.2 Global Cyazofamid Revenue Market Share by Region (2020-2025)
2.3 Global Cyazofamid Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Cyazofamid Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Cyazofamid Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Cyazofamid Market Size and Prospective (2020-2031)
2.4.2 Europe Cyazofamid Market Size and Prospective (2020-2031)
2.4.3 China Cyazofamid Market Size and Prospective (2020-2031)
2.4.4 Japan Cyazofamid Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Cyazofamid Historic Market Review by Type (2020-2025)
3.1.1 Global Cyazofamid Sales by Type (2020-2025)
3.1.2 Global Cyazofamid Revenue by Type (2020-2025)
3.1.3 Global Cyazofamid Price by Type (2020-2025)
3.2 Global Cyazofamid Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Cyazofamid Sales Forecast by Type (2026-2031)
3.2.2 Global Cyazofamid Revenue Forecast by Type (2026-2031)
3.2.3 Global Cyazofamid Price Forecast by Type (2026-2031)
3.3 Different Types Cyazofamid Representative Players
4 Global Market Size by Application
4.1 Global Cyazofamid Historic Market Review by Application (2020-2025)
4.1.1 Global Cyazofamid Sales by Application (2020-2025)
4.1.2 Global Cyazofamid Revenue by Application (2020-2025)
4.1.3 Global Cyazofamid Price by Application (2020-2025)
4.2 Global Cyazofamid Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Cyazofamid Sales Forecast by Application (2026-2031)
4.2.2 Global Cyazofamid Revenue Forecast by Application (2026-2031)
4.2.3 Global Cyazofamid Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Cyazofamid Application
5 Competition Landscape by Players
5.1 Global Cyazofamid Sales by Players (2020-2025)
5.2 Global Top Cyazofamid Players by Revenue (2020-2025)
5.3 Global Cyazofamid Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyazofamid as of 2024)
5.4 Global Cyazofamid Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Cyazofamid, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Cyazofamid, Product Type & Application
5.7 Global Key Manufacturers of Cyazofamid, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Cyazofamid Sales by Company
6.1.1.1 North America Cyazofamid Sales by Company (2020-2025)
6.1.1.2 North America Cyazofamid Revenue by Company (2020-2025)
6.1.2 North America Cyazofamid Sales Breakdown by Type (2020-2025)
6.1.3 North America Cyazofamid Sales Breakdown by Application (2020-2025)
6.1.4 North America Cyazofamid Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Cyazofamid Sales by Company
6.2.1.1 Europe Cyazofamid Sales by Company (2020-2025)
6.2.1.2 Europe Cyazofamid Revenue by Company (2020-2025)
6.2.2 Europe Cyazofamid Sales Breakdown by Type (2020-2025)
6.2.3 Europe Cyazofamid Sales Breakdown by Application (2020-2025)
6.2.4 Europe Cyazofamid Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Cyazofamid Sales by Company
6.3.1.1 China Cyazofamid Sales by Company (2020-2025)
6.3.1.2 China Cyazofamid Revenue by Company (2020-2025)
6.3.2 China Cyazofamid Sales Breakdown by Type (2020-2025)
6.3.3 China Cyazofamid Sales Breakdown by Application (2020-2025)
6.3.4 China Cyazofamid Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Cyazofamid Sales by Company
6.4.1.1 Japan Cyazofamid Sales by Company (2020-2025)
6.4.1.2 Japan Cyazofamid Revenue by Company (2020-2025)
6.4.2 Japan Cyazofamid Sales Breakdown by Type (2020-2025)
6.4.3 Japan Cyazofamid Sales Breakdown by Application (2020-2025)
6.4.4 Japan Cyazofamid Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 ISHIHARA SANGYO KAISHA
7.1.1 ISHIHARA SANGYO KAISHA Company Information
7.1.2 ISHIHARA SANGYO KAISHA Business Overview
7.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Revenue and Gross Margin (2020-2025)
7.1.4 ISHIHARA SANGYO KAISHA Cyazofamid Products Offered
7.1.5 ISHIHARA SANGYO KAISHA Recent Development
7.2 Rudong Zhongyi
7.2.1 Rudong Zhongyi Company Information
7.2.2 Rudong Zhongyi Business Overview
7.2.3 Rudong Zhongyi Cyazofamid Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Rudong Zhongyi Cyazofamid Products Offered
7.2.5 Rudong Zhongyi Recent Development
8 Cyazofamid Manufacturing Cost Analysis
8.1 Cyazofamid Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Cyazofamid
8.4 Cyazofamid Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Cyazofamid Distributors List
9.3 Cyazofamid Customers
10 Cyazofamid Market Dynamics
10.1 Cyazofamid Industry Trends
10.2 Cyazofamid Market Drivers
10.3 Cyazofamid Market Challenges
10.4 Cyazofamid Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Cyazofamid Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Cyazofamid Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Cyazofamid Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Cyazofamid Sales (K MT) by Region (2020-2025)
Table 5. Global Cyazofamid Sales Market Share by Region (2020-2025)
Table 6. Global Cyazofamid Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Cyazofamid Revenue Share by Region (2020-2025)
Table 8. Global Cyazofamid Sales (K MT) Forecast by Region (2026-2031)
Table 9. Global Cyazofamid Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Cyazofamid Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Cyazofamid Revenue Share Forecast by Region (2026-2031)
Table 12. Global Cyazofamid Sales by Type (K MT) & (2020-2025)
Table 13. Global Cyazofamid Sales Share by Type (2020-2025)
Table 14. Global Cyazofamid Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Cyazofamid Price by Type (USD/MT) & (2020-2025)
Table 16. Global Cyazofamid Sales by Type (K MT) & (2026-2031)
Table 17. Global Cyazofamid Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Cyazofamid Price by Type (USD/MT) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Cyazofamid Sales by Application (K MT) & (2020-2025)
Table 21. Global Cyazofamid Sales Share by Application (2020-2025)
Table 22. Global Cyazofamid Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Cyazofamid Price by Application (USD/MT) & (2020-2025)
Table 24. Global Cyazofamid Sales by Application (K MT) & (2026-2031)
Table 25. Global Cyazofamid Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Cyazofamid Price by Application (USD/MT) & (2026-2031)
Table 27. New Sources of Growth in Cyazofamid Application
Table 28. Global Cyazofamid Sales by Company (K MT) & (2020-2025)
Table 29. Global Cyazofamid Sales Share by Company (2020-2025)
Table 30. Global Cyazofamid Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Cyazofamid Revenue Share by Company (2020-2025)
Table 32. Global Cyazofamid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyazofamid as of 2024)
Table 33. Global Market Cyazofamid Average Price by Company (USD/MT) & (2020-2025)
Table 34. Global Key Manufacturers of Cyazofamid, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Cyazofamid, Product Type & Application
Table 36. Global Key Manufacturers of Cyazofamid, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 39. North America Cyazofamid Sales Market Share by Company (2020-2025)
Table 40. North America Cyazofamid Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Cyazofamid Revenue Market Share by Company (2020-2025)
Table 42. North America Cyazofamid Sales by Type (2020-2025) & (K MT)
Table 43. North America Cyazofamid Sales Market Share by Type (2020-2025)
Table 44. North America Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 45. North America Cyazofamid Sales Market Share by Application (2020-2025)
Table 46. Europe Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 47. Europe Cyazofamid Sales Market Share by Company (2020-2025)
Table 48. Europe Cyazofamid Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Cyazofamid Revenue Market Share by Company (2020-2025)
Table 50. Europe Cyazofamid Sales by Type (2020-2025) & (K MT)
Table 51. Europe Cyazofamid Sales Market Share by Type (2020-2025)
Table 52. Europe Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 53. Europe Cyazofamid Sales Market Share by Application (2020-2025)
Table 54. China Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 55. China Cyazofamid Sales Market Share by Company (2020-2025)
Table 56. China Cyazofamid Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Cyazofamid Revenue Market Share by Company (2020-2025)
Table 58. China Cyazofamid Sales by Type (2020-2025) & (K MT)
Table 59. China Cyazofamid Sales Market Share by Type (2020-2025)
Table 60. China Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 61. China Cyazofamid Sales Market Share by Application (2020-2025)
Table 62. Japan Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 63. Japan Cyazofamid Sales Market Share by Company (2020-2025)
Table 64. Japan Cyazofamid Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Cyazofamid Revenue Market Share by Company (2020-2025)
Table 66. Japan Cyazofamid Sales by Type (2020-2025) & (K MT)
Table 67. Japan Cyazofamid Sales Market Share by Type (2020-2025)
Table 68. Japan Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 69. Japan Cyazofamid Sales Market Share by Application (2020-2025)
Table 70. ISHIHARA SANGYO KAISHA Company Information
Table 71. ISHIHARA SANGYO KAISHA Description and Business Overview
Table 72. ISHIHARA SANGYO KAISHA Cyazofamid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. ISHIHARA SANGYO KAISHA Cyazofamid Product
Table 74. ISHIHARA SANGYO KAISHA Recent Development
Table 75. Rudong Zhongyi Company Information
Table 76. Rudong Zhongyi Description and Business Overview
Table 77. Rudong Zhongyi Cyazofamid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Rudong Zhongyi Cyazofamid Product
Table 79. Rudong Zhongyi Recent Development
Table 80. Production Base and Market Concentration Rate of Raw Material
Table 81. Key Suppliers of Raw Materials
Table 82. Cyazofamid Distributors List
Table 83. Cyazofamid Customers List
Table 84. Cyazofamid Market Trends
Table 85. Cyazofamid Market Drivers
Table 86. Cyazofamid Market Challenges
Table 87. Cyazofamid Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyazofamid Product Picture
Figure 2. Global Cyazofamid Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Cyazofamid Sales Market Share by Type in 2024 & 2031
Figure 4. Agriculture Grade Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cyazofamid Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Cyazofamid Sales Market Share by Application in 2024 & 2031
Figure 8. Downy Mildew Examples
Figure 9. Oomycetes Diseases Examples
Figure 10. Others Examples
Figure 11. Global Cyazofamid Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cyazofamid Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 14. Global Cyazofamid Price Trends Growth Rate (2020-2031) & (USD/MT)
Figure 15. Cyazofamid Report Years Considered
Figure 16. Global Market Cyazofamid Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Cyazofamid Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Cyazofamid Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 20. Europe Cyazofamid Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 22. China Cyazofamid Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 24. Japan Cyazofamid Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 26. Global Cyazofamid Revenue Share by Type (2020-2025)
Figure 27. Global Cyazofamid Sales Share by Type (2026-2031)
Figure 28. Global Cyazofamid Revenue Share by Type (2026-2031)
Figure 29. Global Cyazofamid Revenue Share by Application (2020-2025)
Figure 30. Global Cyazofamid Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Cyazofamid Sales Share by Application (2026-2031)
Figure 32. Global Cyazofamid Revenue Share by Application (2026-2031)
Figure 33. Global Cyazofamid Sales Share by Company (2024)
Figure 34. Global Cyazofamid Revenue Share by Company (2024)
Figure 35. Global 5 Largest Cyazofamid Players Market Share by Revenue in Cyazofamid: 2020 & 2024
Figure 36. Cyazofamid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Cyazofamid
Figure 38. Manufacturing Process Analysis of Cyazofamid
Figure 39. Cyazofamid Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Table 1. Global Cyazofamid Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Cyazofamid Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Cyazofamid Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Cyazofamid Sales (K MT) by Region (2020-2025)
Table 5. Global Cyazofamid Sales Market Share by Region (2020-2025)
Table 6. Global Cyazofamid Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Cyazofamid Revenue Share by Region (2020-2025)
Table 8. Global Cyazofamid Sales (K MT) Forecast by Region (2026-2031)
Table 9. Global Cyazofamid Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Cyazofamid Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Cyazofamid Revenue Share Forecast by Region (2026-2031)
Table 12. Global Cyazofamid Sales by Type (K MT) & (2020-2025)
Table 13. Global Cyazofamid Sales Share by Type (2020-2025)
Table 14. Global Cyazofamid Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Cyazofamid Price by Type (USD/MT) & (2020-2025)
Table 16. Global Cyazofamid Sales by Type (K MT) & (2026-2031)
Table 17. Global Cyazofamid Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Cyazofamid Price by Type (USD/MT) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Cyazofamid Sales by Application (K MT) & (2020-2025)
Table 21. Global Cyazofamid Sales Share by Application (2020-2025)
Table 22. Global Cyazofamid Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Cyazofamid Price by Application (USD/MT) & (2020-2025)
Table 24. Global Cyazofamid Sales by Application (K MT) & (2026-2031)
Table 25. Global Cyazofamid Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Cyazofamid Price by Application (USD/MT) & (2026-2031)
Table 27. New Sources of Growth in Cyazofamid Application
Table 28. Global Cyazofamid Sales by Company (K MT) & (2020-2025)
Table 29. Global Cyazofamid Sales Share by Company (2020-2025)
Table 30. Global Cyazofamid Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Cyazofamid Revenue Share by Company (2020-2025)
Table 32. Global Cyazofamid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyazofamid as of 2024)
Table 33. Global Market Cyazofamid Average Price by Company (USD/MT) & (2020-2025)
Table 34. Global Key Manufacturers of Cyazofamid, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Cyazofamid, Product Type & Application
Table 36. Global Key Manufacturers of Cyazofamid, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 39. North America Cyazofamid Sales Market Share by Company (2020-2025)
Table 40. North America Cyazofamid Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Cyazofamid Revenue Market Share by Company (2020-2025)
Table 42. North America Cyazofamid Sales by Type (2020-2025) & (K MT)
Table 43. North America Cyazofamid Sales Market Share by Type (2020-2025)
Table 44. North America Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 45. North America Cyazofamid Sales Market Share by Application (2020-2025)
Table 46. Europe Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 47. Europe Cyazofamid Sales Market Share by Company (2020-2025)
Table 48. Europe Cyazofamid Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Cyazofamid Revenue Market Share by Company (2020-2025)
Table 50. Europe Cyazofamid Sales by Type (2020-2025) & (K MT)
Table 51. Europe Cyazofamid Sales Market Share by Type (2020-2025)
Table 52. Europe Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 53. Europe Cyazofamid Sales Market Share by Application (2020-2025)
Table 54. China Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 55. China Cyazofamid Sales Market Share by Company (2020-2025)
Table 56. China Cyazofamid Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Cyazofamid Revenue Market Share by Company (2020-2025)
Table 58. China Cyazofamid Sales by Type (2020-2025) & (K MT)
Table 59. China Cyazofamid Sales Market Share by Type (2020-2025)
Table 60. China Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 61. China Cyazofamid Sales Market Share by Application (2020-2025)
Table 62. Japan Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 63. Japan Cyazofamid Sales Market Share by Company (2020-2025)
Table 64. Japan Cyazofamid Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Cyazofamid Revenue Market Share by Company (2020-2025)
Table 66. Japan Cyazofamid Sales by Type (2020-2025) & (K MT)
Table 67. Japan Cyazofamid Sales Market Share by Type (2020-2025)
Table 68. Japan Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 69. Japan Cyazofamid Sales Market Share by Application (2020-2025)
Table 70. ISHIHARA SANGYO KAISHA Company Information
Table 71. ISHIHARA SANGYO KAISHA Description and Business Overview
Table 72. ISHIHARA SANGYO KAISHA Cyazofamid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. ISHIHARA SANGYO KAISHA Cyazofamid Product
Table 74. ISHIHARA SANGYO KAISHA Recent Development
Table 75. Rudong Zhongyi Company Information
Table 76. Rudong Zhongyi Description and Business Overview
Table 77. Rudong Zhongyi Cyazofamid Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Rudong Zhongyi Cyazofamid Product
Table 79. Rudong Zhongyi Recent Development
Table 80. Production Base and Market Concentration Rate of Raw Material
Table 81. Key Suppliers of Raw Materials
Table 82. Cyazofamid Distributors List
Table 83. Cyazofamid Customers List
Table 84. Cyazofamid Market Trends
Table 85. Cyazofamid Market Drivers
Table 86. Cyazofamid Market Challenges
Table 87. Cyazofamid Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyazofamid Product Picture
Figure 2. Global Cyazofamid Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Cyazofamid Sales Market Share by Type in 2024 & 2031
Figure 4. Agriculture Grade Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cyazofamid Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Cyazofamid Sales Market Share by Application in 2024 & 2031
Figure 8. Downy Mildew Examples
Figure 9. Oomycetes Diseases Examples
Figure 10. Others Examples
Figure 11. Global Cyazofamid Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cyazofamid Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 14. Global Cyazofamid Price Trends Growth Rate (2020-2031) & (USD/MT)
Figure 15. Cyazofamid Report Years Considered
Figure 16. Global Market Cyazofamid Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Cyazofamid Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Cyazofamid Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 20. Europe Cyazofamid Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 22. China Cyazofamid Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 24. Japan Cyazofamid Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Cyazofamid Sales (K MT) Growth Rate (2020-2031)
Figure 26. Global Cyazofamid Revenue Share by Type (2020-2025)
Figure 27. Global Cyazofamid Sales Share by Type (2026-2031)
Figure 28. Global Cyazofamid Revenue Share by Type (2026-2031)
Figure 29. Global Cyazofamid Revenue Share by Application (2020-2025)
Figure 30. Global Cyazofamid Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Cyazofamid Sales Share by Application (2026-2031)
Figure 32. Global Cyazofamid Revenue Share by Application (2026-2031)
Figure 33. Global Cyazofamid Sales Share by Company (2024)
Figure 34. Global Cyazofamid Revenue Share by Company (2024)
Figure 35. Global 5 Largest Cyazofamid Players Market Share by Revenue in Cyazofamid: 2020 & 2024
Figure 36. Cyazofamid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Cyazofamid
Figure 38. Manufacturing Process Analysis of Cyazofamid
Figure 39. Cyazofamid Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Mining Truck Mounted Drill Rigs Market Research Report 2025
Apr 07, 25
Global Bulk Material Drag Chain Conveyor Market Research Report 2025
Apr 07, 25
Global Boom-type Mining Roadheader Market Research Report 2025
Apr 07, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232